Literature DB >> 12430901

Monitoring the course of chronic myelogenous leukemia by fluorescence in situ hybridization.

Chu-Myong Seong1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12430901     DOI： 10.1007/bf03165087

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  17 in total

1.  Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.

Authors:  D C Tkachuk; C A Westbrook; M Andreeff; T A Donlon; M L Cleary; K Suryanarayan; M Homge; A Redner; J Gray; D Pinkel
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

Review 2.  Analysis of genes and chromosomes by nonisotopic in situ hybridization.

Authors:  P Lichter; A L Boyle; T Cremer; D C Ward
Journal:  Genet Anal Tech Appl       Date:  1991-02

3.  Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.

Authors:  D Seong; P Thall; H M Kantarjian; M Talpaz; J Swantkowski; J Xu; Y Shen; A Glassman; L Ramagli; M J Siciliano
Journal:  Clin Cancer Res       Date:  1998-04       Impact factor: 12.531

Review 4.  Mapping and chromosome analysis: the potential of fluorescence in situ hybridization.

Authors:  S Joos; T M Fink; A Rätsch; P Lichter
Journal:  J Biotechnol       Date:  1994-06-30       Impact factor: 3.307

5.  Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia.

Authors:  D Seong; S Giralt; H Fischer; K Hayes; A Glassman; R Arlinghaus; J Xu; H Kantarjian; M Siciliano; R Champlin
Journal:  Bone Marrow Transplant       Date:  1997-03       Impact factor: 5.483

6.  Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

Authors:  F van Rhee; F Lin; J O Cullis; A Spencer; N C Cross; A Chase; B Garicochea; J Bungey; J Barrett; J M Goldman
Journal:  Blood       Date:  1994-06-01       Impact factor: 22.113

7.  Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.

Authors:  H M Kantarjian; T L Smith; K B McCredie; M J Keating; R S Walters; M Talpaz; J P Hester; G Bligham; E Gehan; E J Freireich
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

8.  Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.

Authors:  D C Seong; H M Kantarjian; J Y Ro; M Talpaz; J Xu; J R Robinson; A B Deisseroth; R E Champlin; M J Siciliano
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

9.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Authors:  H J Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; D Niederwieser; F van Rhee; J Mittermueller; T de Witte; E Holler; H Ansari
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

10.  Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia.

Authors:  A M Potter; A E Watmore; P Cooke; J S Lilleyman; R J Sokol
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.